GlassScriptPhysician profile
Lawrence Thomas Weir
NPI 1114008679
$2,237.96
in general payments reported to CMS, 2019-2025
8 companies · $464 in 2025
The $464 reported for 2025 was more than what 90% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.44 · 2020: $12.99 · 2021: $13.00 · 2022: $777 · 2023: $667 · 2024: $292 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864 · Consulting Fee: $400 · Gift: $138 · Education: $21.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.63 |
| Consulting Fee | $400.00 |
| Gift | $138.04 |
| Education | $21.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $922.69 | 2022-2024 | Opalescence |
| Nobel Biocare USA | $475.54 | 2023 | Nobelactive |
| Dentsply LLC | $400.00 | 2025 | |
| Straumann USA LLC | $380.22 | 2022-2025 | |
| Envista Holdings Corporation | $21.08 | 2025 | Zirconia Abutment Preparation Kit |
| Kuraray America INC. | $13.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $12.99 | 2020 | |
| Dentsply Sirona INC | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Weir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.